Kaplan C P, Miner M E, Mervis L, Newton H, McGregor J M, Goodman J H
Division of Neurologic Surgery, Ohio State University, Columbus, USA.
Brain Inj. 1998 Mar;12(3):199-205. doi: 10.1080/026990598122674.
Patients with brain tumours often report distress. Interpretive problems ensue when measures normed on healthy persons are utilized to quantify distress. This study investigated potentially spurious elevations on the Hopkins Symptom Checklist 90 Revised (SCL 90-R). Responses of 17 patients were obtained prior to aggressive chemotherapy. Traditional interpretation indicated that 47% of the patients endorsed clinical levels of somatization, 53% obsessive-compulsive and 59% psychotic disorders. Elevations were attributable to common consequences of brain tumours, medication and the emotional reaction to prognosis. Conventional interpretation would lead to inappropriate classifications. The majority of SCL 90-R item endorsements were significantly different than those of the norm group. Appropriate interpretation of scores is discussed.
脑肿瘤患者常诉说痛苦。当使用针对健康人群标准化的测量方法来量化痛苦时，就会出现解释问题。本研究调查了霍普金斯症状清单90修订版（SCL 90-R）上可能存在的虚假升高情况。在积极化疗前获取了17名患者的反应。传统解释表明，47%的患者认可躯体化症状的临床水平，53%认可强迫症状，59%认可精神障碍症状。这些升高归因于脑肿瘤、药物治疗的常见后果以及对预后的情绪反应。传统解释会导致不恰当的分类。SCL 90-R大多数项目的认可情况与常模组有显著差异。文中讨论了对分数的恰当解释。
